The increase in TNF expression at baseline in CD56bright cells has already been evidenced in some inflammatory skin diseases (lichen planus, psoriasis, Sezary’s syndrome, and mycosis fungoides), as well as in our findings in adults with AD26,27. This evidence concerns the gene TNF and Sezary syndrome.